CASELLI, Emilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.897
AS - Asia 4.491
EU - Europa 3.856
SA - Sud America 599
AF - Africa 88
OC - Oceania 10
Totale 16.941
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.724
SG - Singapore 1.369
CN - Cina 1.215
IT - Italia 1.028
GB - Regno Unito 814
SE - Svezia 505
VN - Vietnam 502
HK - Hong Kong 489
BR - Brasile 442
DE - Germania 365
RU - Federazione Russa 198
KR - Corea 190
FI - Finlandia 187
FR - Francia 167
UA - Ucraina 159
BD - Bangladesh 143
TR - Turchia 130
IN - India 111
CA - Canada 91
ID - Indonesia 66
BG - Bulgaria 65
JP - Giappone 61
BE - Belgio 60
NL - Olanda 57
MX - Messico 55
IE - Irlanda 50
PL - Polonia 44
ES - Italia 41
AR - Argentina 38
IQ - Iraq 35
RO - Romania 30
EC - Ecuador 27
PK - Pakistan 27
CO - Colombia 24
ZA - Sudafrica 23
AT - Austria 20
MA - Marocco 20
CL - Cile 18
MY - Malesia 18
AE - Emirati Arabi Uniti 17
LT - Lituania 17
VE - Venezuela 15
SA - Arabia Saudita 13
UZ - Uzbekistan 13
PE - Perù 12
KZ - Kazakistan 10
TW - Taiwan 10
AZ - Azerbaigian 9
JO - Giordania 8
KE - Kenya 8
PH - Filippine 8
PY - Paraguay 8
TN - Tunisia 8
AU - Australia 7
BO - Bolivia 7
IL - Israele 7
CH - Svizzera 6
MD - Moldavia 6
AL - Albania 5
DZ - Algeria 5
ET - Etiopia 5
JM - Giamaica 5
QA - Qatar 5
SC - Seychelles 5
TH - Thailandia 5
UY - Uruguay 5
CI - Costa d'Avorio 4
EG - Egitto 4
IR - Iran 4
LB - Libano 4
NO - Norvegia 4
NP - Nepal 4
PS - Palestinian Territory 4
BH - Bahrain 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
GR - Grecia 3
GT - Guatemala 3
KG - Kirghizistan 3
NI - Nicaragua 3
PA - Panama 3
PT - Portogallo 3
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
KW - Kuwait 2
LV - Lettonia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BZ - Belize 1
Totale 16.925
Salva come PNG Salva come JPEG
Città #
Singapore 876
Santa Clara 784
Ashburn 708
Chandler 517
Fairfield 475
Hong Kong 474
Hefei 454
Woodbridge 448
Southend 419
San Jose 330
Jacksonville 304
Ann Arbor 263
Nyköping 262
Houston 240
Council Bluffs 214
London 211
Cambridge 209
Dearborn 206
Seattle 196
Beijing 192
Wilmington 190
Modena 180
Ho Chi Minh City 148
Helsinki 135
Dallas 134
Los Angeles 132
Seoul 130
Chicago 111
Hanoi 111
Berlin 108
The Dalles 98
Milan 88
New York 86
Princeton 61
Sofia 61
Lauterbourg 55
San Diego 53
Redwood City 52
Eugene 48
Shanghai 48
Des Moines 47
Dublin 47
São Paulo 47
Izmir 42
Jakarta 40
Moscow 40
Frankfurt am Main 39
Salt Lake City 39
Tokyo 39
Brussels 38
Buffalo 38
Reggio Emilia 37
Warsaw 34
Parma 33
Amsterdam 32
Bologna 31
Orem 29
Mexico City 28
Munich 28
Phoenix 28
Yalova 28
Florence 27
Boardman 25
Atlanta 24
Brooklyn 23
Da Nang 22
Chennai 21
Elk Grove Village 21
Tampa 21
Timisoara 21
Columbus 20
Toronto 20
Turin 20
Falls Church 19
Guangzhou 19
Menlo Park 19
Nuremberg 19
Haiphong 18
Pedara 18
Fuzhou 17
Bremen 16
Fremont 16
Kent 16
Rome 16
San Francisco 16
Austin 15
Formigine 15
Seongnam 15
Vancouver 15
Washington 15
Boston 14
Denver 14
Dong Ket 14
Ghent 14
Montreal 14
Dhaka 13
Norwalk 13
Rio de Janeiro 13
Guayaquil 12
Johannesburg 12
Totale 11.257
Salva come PNG Salva come JPEG
Nome #
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening 972
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase 823
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors 410
Chemo-enzymatic synthesis of levodropropizine 386
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 382
Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa 367
Boronic acid transition state inhibitors active against KPC and other class a β-lactamases: Structure-activity relationships as a guide to inhibitor design 367
(S)-(+)-N-acetylphenylglycineboronic acid: A chiral derivatizing agent for Ee determination of 1,2-diols 345
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii 332
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 329
Acetamidomethaneboronic acids bearing the R1 side chains of beta-lactams as inhibitors of beta-lactamase enzymes 324
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030 321
Inhibiting the β-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs) 317
Boronic acid inhibitors of beta-lactamases as therapeutic agents in treatment of antibiotic-resistant infection diseases 312
Design, synthesis, crystal structures and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors 307
Sintesi Stereoselettiva di Acidi Boronici Inibitori di beta-Lattamasi 304
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 301
Enantiomeric excess of 1,2-diols by formation of cyclic boronates: an improved method 291
One-Pot Synthesis of Imidazole-4-Carboxylates by Microwave-Assisted1,5-Electrocyclization of Azavinyl Azomethine Ylides 287
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 284
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii 283
Nanomolar inhibitors of AmpC beta-lactamase 275
Acido alfa-Acetammido-alfa-Fenilmetanboronico come Agente Derivatizzante Chirale per la Determinazione dell’Eccesso Enantiomerico di 1,2-Dioli 272
Sulfonamido-substituted boronic acids as β-lactamase inhibitors for treatment of antibiotic-resistant bacterial infections 263
Negative Epistasis and Evolvability in TEM-1 β-Lactamase—The Thin Line between an Enzyme's Conformational Freedom and Disorder 262
Design and exploration of novel boronic acid Inhibitors reveals important Interactions with a clavulanic acid-resistant sulfhydryl- variable (SHV) β‑ lactamase 258
Lipase-Catalyzed Resolution and Desymmetrization of 2-Hydroxymethylaziridines 256
α-Aminoester-Derived Imidazoles by 1,5-Electrocyclization of Azavinyl Azomethine Ylides 256
Highly enantioselective reduction of ethyl 4-chloro-3-oxobutanoate to L-and D-3-hydroxyesters with baker`s yeast 251
Inhibition of Acinetobacter -Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors 247
Fragment-guided Design of Subnanomolar β-Lactamase Inhibitors Active in vivo 243
The structures of Ceftazidime and Its Transition State Analog in Complex with AmpC-beta-lactamase: Implication for Resistance Mutation and Inhibitor Design 242
Straightforward synthesis of chiral non-racemic α-boryl isocyanides 242
Exploring sequence requirements for C3/C4 carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase 241
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses 237
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 236
A method of treating a bacterial infection in a subject in need thereof includes administering to the subject therapeutically effective amts. of at least one β-lactam antibiotic and at least one triazolylmethyl boronic acid β-lactamase inhibitor. 233
Structure-based design and in-parallel synthesis of inhibitors of AmpC β-lactamase 231
Synthesis of [(1,2,3-Triazol-1-yl)methyl]boronic Acids Through Click Chemistry: Easy Access to a Potential Scaffold for Protease Inhibitors 226
Structure-based optimization of cephalotin analogue boronic acids as beta-lactamase inhibitors 224
Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase 223
Using Boronic Acid Transition State Inhibitors to understand the extended spectrum (ES) and carbapenemase phenotypes of class A beta-lactamases in Klebsiella pneumoniae 216
Recognition and resistance in TEM beta-lactamase 206
Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases 205
Exploring novel inhibitors of FOX-4 Class C β-lactamase 199
α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs 197
Stereoselective synthesis of erythro beta-substituted aspartates 196
Structures of FOX-4 cephamycinase in complex with transition-state analog inhibitors 196
Inhibition of the Class C β-Lactamase from Acinetobacter spp.: Insights into Effective Inhibitor Design 194
The role of a second-shell residue in modifying substrate and inhibitor interactions in the SHV β-lactamase: A study of Ambler position Asn276 184
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum 179
Structure-Based Design and In Parallel Synthesis of Boronic Acid Inhibitors of AmpC 61538;-Lactamase 173
Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii 169
α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML 169
Structure-based design and solid phase synthesis of novel AmpC b-lactamase inhibitors 167
Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates 166
Progettazione, Sintesi ed Attività di Acidi 1-Acilamminoalcanboronici Inibitori di beta-Lattamasi 165
Interactions of Oxyimino-Substituted Boronic Acids and β-Lactams with the CMY-2-Derived Extended-Spectrum Cephalosporinases CMY-30 and CMY-42 165
Structural Insights into Inhibition of the Acinetobacter-Derived Cephalosporinase ADC-7 by Ceftazidime and Its Boronic Acid Transition State Analog 165
Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor 161
Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry 134
Boronate-Based Inhibitors of Penicillin-Binding Proteins: An Underestimated Avenue for Antibiotic Discovery? 123
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas-derived cephalosporinase 107
Structural Studies of Inhibition of β-Lactamases by Boronic Acid Transition State Analogs and a Penam Sulfone 105
Restoring cefepime activity against multidrug-resistant KPC-producing Klebsiella pneumoniae by combination with boronic acid inhibitors, MB076 and S02030 86
Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the Acinetobacter-derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant Acinetobacter baumannii (CRAb) 82
Totale 17.071
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 0 0 79
2021/20221.248 81 116 86 106 68 109 48 88 144 88 187 127
2022/20231.532 186 174 113 161 173 222 38 120 180 20 55 90
2023/2024988 38 76 49 104 186 92 143 78 26 32 53 111
2024/20253.060 110 65 70 178 536 456 205 228 301 84 337 490
2025/20266.143 376 334 587 784 876 516 665 232 532 621 417 203
Totale 17.071